adverse events have been linked to their use. Furthermore, there Is a significant
discrepancy between the prevalence of mental health disorders and BZD drug use In
the elderly population, which can be attributed to a measurement issue. The goal of
this cross-sectional descriptive study was to determine the prevalence of mental
health disorders among seniors using BZD and living in the community, basing this
information on both a thorough face-to-face interview and a pair of self-reported
validated instruments. Among the 216 seniors recruited in our study, nearly 20 %
were users of BZD and over three quarters of them had been using this drug for
more than a year. Thirteen subjects were recognized as depressed according to a
self-report measure compared to 18 according to the interview